SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

American Renal Associates Holdings, Inc. – ‘S-8’ on 4/22/16 – EX-5.1

On:  Friday, 4/22/16, at 4:10pm ET   ·   Effective:  4/22/16   ·   Accession #:  1104659-16-113525   ·   File #:  333-210870

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 4/22/16  American Renal Assocs Holdin… Inc S-8         4/22/16    5:343K                                   Merrill Corp-MD/FA

Registration of Securities to be Offered to Employees Pursuant to an Employee Benefit Plan   —   Form S-8
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-8         Registration of Securities to be Offered to         HTML     78K 
                          Employees Pursuant to an Employee                      
                          Benefit Plan                                           
 2: EX-4.3      Instrument Defining the Rights of Security Holders  HTML     83K 
 3: EX-4.4      Instrument Defining the Rights of Security Holders  HTML     71K 
 4: EX-5.1      Opinion re: Legality                                HTML     13K 
 5: EX-23.2     Consent of Experts or Counsel                       HTML      7K 


EX-5.1   —   Opinion re: Legality


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



Exhibit 5.1

 

American Renal Associates Holdings, Inc.

500 Cummings Center, Suite 6550

Beverly, Massachusetts 01915

 

April 22, 2016

 

American Renal Associates Holdings, Inc.

500 Cummings Center, Suite 6550

Beverly, Massachusetts 01915

 

Ladies and Gentlemen:

 

I am the Vice President and General Counsel of American Renal Associates Holdings, Inc., a Delaware corporation (the “Company”), and I am delivering this opinion in connection with the Registration Statement on Form S-8 (the “Registration Statement”) filed by the Company with the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Act”), relating to (1) up to 4,000,000 shares (the “2016 Plan Shares”) of common stock, par value $0.01 per share, of the Company (the “Common Stock”), that may be issued by the Company pursuant to the American Renal Associates Holdings, Inc. 2016 Omnibus Incentive Plan (the “2016 Plan”), (2) up to 34,350 shares (the “2011 Plan Shares”) of Common Stock that may be issued by the Company pursuant to the American Renal Associates Holdings, Inc. 2011 Stock Option Plan for Nonemployee Directors (the “2011 Nonemployee Director Plan”), (3) up to 5,591,708 shares (the “2010 Plan Shares”) of Common Stock that may be issued by the Company pursuant to the American Renal Associates Holdings, Inc. 2010 Stock Incentive Plan, (the “2010 Plan”), (4) up to 115,936 shares (the “2005 Plan Shares”) of Common Stock that may be issued by the Company pursuant to the American Renal Holdings Inc. 2005 Equity Incentive Plan (the “2005 Plan”) and (5) up to

 



 

4,093 shares (the “2000 Plan Shares” and, together with the 2016 Plan Shares, the 2011 Plan Shares, the 2010 Plan Shares and the 2005 Plan Shares, the “Shares”) of Common Stock that may be issued by the Company pursuant to the American Renal Associates, Inc. 2000 Equity Incentive Plan (the “2000 Plan” and, together with the 2015 Plan, the 2011 Nonemployee Director Plan, the 2010 Plan and the 2005 Plan, the “Plans”).

 

I and/or other lawyers under my supervision have examined the Registration Statement, a form of the Amended and Restated Certificate of Incorporation of the Company and the Plans, which have been filed with the Commission as exhibits to the Registration Statement. In addition, I and/or other lawyers under my supervision have examined the originals, or duplicates or certified or conformed copies, of such records, agreements, documents and other instruments and have made such other investigations as I have deemed relevant and necessary in connection with the opinions hereinafter set forth.  As to questions of fact material to this opinion, I have relied upon certificates or comparable documents of public officials and of officers and representatives of the Company.

 

In rendering the opinion set forth below, I have assumed the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted to me as originals, the conformity to original documents of all documents submitted to me as duplicates or certified or conformed copies and the authenticity of the originals of such latter documents.

 

Based upon the foregoing, and subject to the qualifications, assumptions and limitations stated herein, I am of the opinion that upon issuance and delivery in accordance with the applicable Plan, the Shares will be validly issued, fully paid and nonassessable.

 

2



 

I hereby consent to the filing of this opinion letter as Exhibit 5.1 to the Registration Statement. In giving this consent, I do not thereby admit that I come into the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission promulgated thereunder.

 

 

Very truly yours,

 

 

 

 

 

/s/ Michael R. Costa

 

 

 

Michael R. Costa, Esq.

 

Vice President and General Counsel of the Company

 

3



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-8’ Filing    Date    Other Filings
Filed on / Effective on:4/22/163,  424B4
 List all Filings 
Top
Filing Submission 0001104659-16-113525   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 15, 6:49:19.1pm ET